Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Journey Medical (DERM) Net Cash Flow (2020 - 2025)

Historic Net Cash Flow for Journey Medical (DERM) over the last 6 years, with Q3 2025 value amounting to $4.7 million.

  • Journey Medical's Net Cash Flow rose 42081.32% to $4.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $17.5 million, marking a year-over-year increase of 86429.2%. This contributed to the annual value of -$7.1 million for FY2024, which is 5631.03% down from last year.
  • Journey Medical's Net Cash Flow amounted to $4.7 million in Q3 2025, which was up 42081.32% from -$777000.0 recorded in Q2 2025.
  • Journey Medical's 5-year Net Cash Flow high stood at $27.4 million for Q4 2021, and its period low was -$9.1 million during Q2 2023.
  • Over the past 5 years, Journey Medical's median Net Cash Flow value was -$777000.0 (recorded in 2025), while the average stood at $2.1 million.
  • Per our database at Business Quant, Journey Medical's Net Cash Flow skyrocketed by 46431.81% in 2021 and then tumbled by 43586.21% in 2025.
  • Journey Medical's Net Cash Flow (Quarter) stood at $27.4 million in 2021, then plummeted by 110.54% to -$2.9 million in 2022, then soared by 193.14% to $2.7 million in 2023, then surged by 377.47% to $12.8 million in 2024, then tumbled by 63.76% to $4.7 million in 2025.
  • Its last three reported values are $4.7 million in Q3 2025, -$777000.0 for Q2 2025, and $765000.0 during Q1 2025.